Skip to main content

Blog

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Individuals With Duchenne Amenable to Exon 53 Skipping

...

Thanks to You PPMD Continues Forward in All Areas of Support

...

PPMD Contributes to National Academies Report on Rare Disease Regulatory Processes

...

PPMD Community Webinar Recap: Overview of DUVYZAT and Access Resources

...

PPMD & Global Patient Advocacy Groups Award BIND Project $113,000 to Further Brain Involvement Research

...

Navigating Access & Resources

...

Watch the Recording: Advocating for A Successful School Year

...

Setting Up A Successful School Year

...

Raising Our Voices for Duchenne: Recap of PPMD’s Advocacy Webinar

...

Myology Course Educates and Advances Next Generation of Neuromuscular Physicians and Scientists

...